Statement of Principles concerning malignant neoplasm of the bile duct No. 17 of 2000

Administered by Department of Veterans' Affairs

Legislation au F2005B02997 Not in force Legislative Instrument

Legislation content

Instrument No.17 of 2000

 

Revocation and Determination

of

Statement of Principles

concerning

 

MALIGNANT NEOPLASM OF THE BILE DUCT

 

 

ICD-10-AM CODES: C22.1, C24

 

Veterans’ Entitlements Act 1986

 

 

1. The Repatriation Medical Authority under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act):

 

(a) revokes Instrument No.34 of 1999; and

 

(b) determines in its place the following Statement of Principles.

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about osteoarthrosismalignant neoplasm of the bile duct and death from malignant neoplasm of the bile duct.

 

(b) For the purposes of this Statement of Principles:

 

“malignant neoplasm of the bile duct” means a primary malignant neoplasm arising in an intrahepatic or extrahepatic bile duct (including ampulla of Vater, and the cystic duct), attracting ICD-10-AM code C22.1 or C24, but excluding soft tissue sarcoma, non-Hodgkin’s lymphoma and Hodgkin’s disease.


Basis for determining the factors

3. The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that malignant neoplasm of the bile duct and death from malignant neoplasm of the bile duct can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces.

 

Factors that must be related to service

4. Subject to clause 6, at least one of the factors set out in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5. The factors that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the bile duct or death from malignant neoplasm of the bile duct with the circumstances of a person’s relevant service are:

 

(a)               suffering from chronic hepatobiliary infestation by liver flukes before the clinical onset of malignant neoplasm of the bile duct; or

 

(b)              suffering from sclerosing cholangitis before the clinical onset of malignant neoplasm of the bile duct; or

 

(c)                             suffering from ulcerative colitis before the clinical onset of malignant neoplasm of the bile duct; or

 

(d)                            suffering from cholelithiasis before the clinical onset of malignant neoplasm of the bile duct; or

 

(e)               suffering from a chronic typhoid carrier state before the clinical onset of malignant neoplasm of the bile duct; or

 

(f)                having had an intravascular injection of thorotrast before the clinical onset of malignant neoplasm of the bile duct; or

 

(g)              suffering from cirrhosis of the liver before the clinical onset of malignant neoplasm of the bile duct; or

 

(h) inability to obtain appropriate clinical management for malignant neoplasm of the bile duct.

 

Factors that apply only to material contribution or aggravation

6. Paragraph 5(h) applies only to material contribution to, or aggravation of, malignant neoplasm of the bile duct where the person’s malignant neoplasm of the bile duct was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e), 70(5)(d) or 70(5A)(d) of the Act refers.

 

Inclusion of Statements of Principles

7. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8. For the purposes of this Statement of Principles:

 

“cholelithiasis” means calculus of the gall bladder or bile duct formed by accretion or concretion of bile constituents;

 

“chronic typhoid carrier state” means harbouring typhoid bacilli, as determined by examination of at least two specimens of stool taken no less than 24 hours apart, from a person who has not shown clinical evidence of typhoid fever within the 12 months immediately preceding the diagnosis of chronic typhoid carrier state;

 

“cirrhosis of the liver” means a pathologically defined entity involving irreversible chronic injury of the hepatic parenchyma and includes extensive fibrosis in association with regenerative nodules;

 

“death from malignant neoplasm of the bile duct” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s malignant neoplasm of the bile duct;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), Second Edition, effective date of 1 July 2000, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86487 271 3;

 

“liver flukes” means Clonorchis sinensis, Opisthorchis viverrini or Opisthorchis felineus;

 

“relevant service” means:

 

(a) operational service; or

(b) peacekeeping service; or

(c) hazardous service;

 

“sclerosing cholangitis” means a disorder characterised by a progressive, inflammatory, sclerosing and obliterative process in the bile ducts;

 

“terminal event” means the proximate or ultimate cause of death and includes:

 

a) pneumonia;

b) respiratory failure;

c) cardiac arrest;

d) circulatory failure; or

e)                  cessation of brain function;

 

“thorotrast” means a contrast medium formerly used in radiography, which contained thorium dioxide, a radioactive emitter.

 

Application

9. This Instrument applies to all matters to which section 120A of the Act applies.

 

Dated this Twelfth  day of  July 2000

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of    )

KEN DONALD

CHAIRMAN

Overview

The Veterans’ Entitlements Act 1986, enacted by the Commonwealth Parliament, was designed to provide various benefits and entitlements to veterans and their families, addressing the need for comprehensive support for those who have served in the Australian Defence Force. The Act was introduced to fill the gap in recognising and compensating veterans for injuries, diseases, or disabilities incurred or aggravated due to their service. The Repatriation Medical Authority, under the authority vested in it by subsection 196B(2) of the Act, issued Instrument No.17 of 2000, revoking Instrument No.34 of 1999 and establishing a new Statement of Principles concerning malignant neoplasm of the bile duct, its associated death, and related conditions. The policy objective of this legislative instrument is to ensure that veterans suffering from specific medical conditions, such as malignant neoplasm of the bile duct, can access appropriate benefits and recognition of their service-related ailments. The new Statement of Principles identifies malignant neoplasm of the bile duct, including death from such a neoplasm, and outlines the specific factors that must be related to the veteran's service for a reasonable hypothesis to be raised about the connection between the disease and their service. The instrument aims to provide clarity and guidance to veterans and their representatives in pursuing claims related to these conditions. It also ensures that the medical evidence is sound and relevant to the service rendered by the veterans, members of Peacekeeping Forces, or members of the Forces.

Scope and Application

The legislative instrument under the Veterans’ Entitlements Act 1986 revokes a previous Statement of Principles and establishes a new one regarding malignant neoplasm of the bile duct, specifically excluding soft tissue sarcoma, non-Hodgkin’s lymphoma, and Hodgkin’s disease. This legislative instrument applies to veterans, members of Peacekeeping Forces, and members of the Forces who have experienced malignant neoplasm of the bile duct or death from such a condition, provided it meets the specified medical-scientific criteria related to their service. The instrument mandates that at least one of the stipulated factors, such as chronic hepatobiliary infestation by liver flukes or sclerosing cholangitis before the onset of the disease, must be linked to the person's relevant service for the condition to be considered service-related. This Statement of Principles is applicable to all matters governed by section 120A of the Act, ensuring that veterans and other eligible individuals receive appropriate consideration and entitlements for service-related malignant neoplasm of the bile duct.

Key Provisions

The legislation (Instrument No.17 of 2000) primarily revokes the previous Instrument No.34 of 1999 and establishes a new Statement of Principles concerning malignant neoplasm of the bile duct and related death under the Veterans’ Entitlements Act 1986 (the Act). This Statement of Principles aims to establish a causal link between certain conditions and veterans' service (section 1). It outlines that the legislation pertains to malignant neoplasm of the bile duct and death from this condition, providing specific definitions and criteria for these terms (section 2). The Repatriation Medical Authority asserts that there is sufficient medical-scientific evidence supporting a connection between these conditions and relevant military service (section 3). Under the Act, at least one of the specified factors must be related to the veteran's service for a causal link to be considered (section 4). The factors that must exist to raise a reasonable hypothesis of a connection include suffering from chronic hepatobiliary infestation by liver flukes, sclerosing cholangitis, ulcerative colitis, cholelithiasis, chronic typhoid carrier state, an intravascular injection of thorotrast, cirrhosis of the liver, or inability to obtain appropriate clinical management for malignant neoplasm of the bile duct before its onset (section 5). Additionally, paragraph 5(h) applies only to cases where there is a material contribution to or aggravation of the condition, provided the condition was suffered or contracted before or during (but not arising out of) the relevant service (section 6). The legislation also incorporates other relevant Statements of Principles if applicable (section 7). The obligations imposed by this Act include the necessity for veterans to demonstrate a connection between their military service and the specified conditions through the presence of at least one relevant factor (section 4). It also mandates the consideration of other Statements of Principles if applicable, ensuring a comprehensive evaluation of the veteran’s condition in relation to their service (section 7). The legislation does not explicitly outline offences, penalties, or civil/criminal consequences for non-compliance, focusing instead on establishing the criteria for determining the connection between the veteran's service and the specified medical conditions. The primary purpose is to provide clarity and a framework for assessing entitlements related to malignant neoplasm of the bile duct and related death among veterans.

Legal classification tags

Area of Law
Veterans’ Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.